Word

CONJUALL

Status

Pending

Status Code

681

Status Date

Thursday, May 2, 2024

Serial Number

97191384

Mark Type

4

Filing Date

Monday, December 27, 2021

Published for Opposition

Tuesday, June 4, 2024

Trademark Owner History

LEGOCHEM BIOSCIENCES, INC.

Classifications

5 Medicinal preparations for prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases, namely, antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; colostral antibodies and the chemical modifications and conjugates thereof for medical purposes and medical laboratory tests; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; Chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for treatment of rare diseases

42 Scientific study and research in the field(s) of research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; medical and pharmaceutical research services; biological research and analysis; chemical research and analysis; biochemical research and analysis; and scientific research in the nature of conducting clinical trials for others

Trademark Events

Jan 4, 2022

New Application Office Supplied Data Entered

Dec 30, 2021

New Application Entered

Sep 29, 2022

Non-Final Action Written

Sep 28, 2022

Assigned To Examiner

Sep 29, 2022

Non-Final Action E-Mailed

Sep 29, 2022

Notification Of Non-Final Action E-Mailed

Feb 22, 2023

Correspondence Received In Law Office

Feb 22, 2023

Teas/Email Correspondence Entered

Sep 14, 2023

Suspension Inquiry Written

Feb 22, 2023

Teas Response To Office Action Received

Mar 17, 2023

Suspension Letter Written

Mar 17, 2023

Letter Of Suspension E-Mailed

Mar 17, 2023

Notification Of Letter Of Suspension E-Mailed

Sep 14, 2023

Inquiry To Suspension E-Mailed

Sep 14, 2023

Notification Of Inquiry As To Suspension E-Mailed

Sep 27, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Sep 27, 2023

Teas Change Of Correspondence Received

May 2, 2024

Approved For Pub - Principal Register

May 2, 2024

Assigned To Lie

May 2, 2024

Correspondence Received In Law Office

May 2, 2024

Teas/Email Correspondence Entered

Dec 12, 2023

Teas Response To Suspension Inquiry Received

Sep 27, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received